Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Law

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Pathology|July 28, 2010
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphomaDavid K Durnick, Mark E Law, Matthew J Maurer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disordersAndrew P Sciallis, Mark E Law, David J Inwards, et al.
Blood|September 29, 2012
Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOPMamta Gupta, Matthew J Maurer, Linda E Wellik, et al.
Human Pathology|June 10, 2026
GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastasesSelina F Ji, Mark E Law, Jillian C Dawley, et al.
The American Journal of Surgical Pathology|October 15, 2011
Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroupsNazan Ozsan, Brent J Bedke, Mark E Law, et al.
The American Journal of Surgical Pathology|October 3, 2025
Dual TRBC1-CD3 Immunohistochemistry Shows High Diagnostic Utility in Differentiating Mycosis Fungoides/Sezary Syndrome From Reactive Inflammatory Dermatoses in Skin BiopsiesNatasha E Lewis, David J DiCaudo, Jiehao Zhou, et al.
Blood|October 30, 2010
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingAndrew L Feldman, Ahmet Dogan, David I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical courseFrancois M Cady, Brian Patrick O'Neill, Mark E Law, et al.
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalitiesEsteban Braggio, Ahmet Dogan, Jonathan J Keats, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Pathology|July 28, 2010
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphomaDavid K Durnick, Mark E Law, Matthew J Maurer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 6, 2012
Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disordersAndrew P Sciallis, Mark E Law, David J Inwards, et al.
Blood|September 29, 2012
Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOPMamta Gupta, Matthew J Maurer, Linda E Wellik, et al.
Human Pathology|June 10, 2026
GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastasesSelina F Ji, Mark E Law, Jillian C Dawley, et al.
The American Journal of Surgical Pathology|October 15, 2011
Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroupsNazan Ozsan, Brent J Bedke, Mark E Law, et al.
The American Journal of Surgical Pathology|October 3, 2025
Dual TRBC1-CD3 Immunohistochemistry Shows High Diagnostic Utility in Differentiating Mycosis Fungoides/Sezary Syndrome From Reactive Inflammatory Dermatoses in Skin BiopsiesNatasha E Lewis, David J DiCaudo, Jiehao Zhou, et al.
Blood|October 30, 2010
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencingAndrew L Feldman, Ahmet Dogan, David I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical courseFrancois M Cady, Brian Patrick O'Neill, Mark E Law, et al.
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2012
Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalitiesEsteban Braggio, Ahmet Dogan, Jonathan J Keats, et al.
Pageof 3